Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
EGS Beteiligungen

EGS Beteiligungen

● Actively deploying Zürich, Switzerland · Founded 2009

Investment thesis

EGS Beteiligungen is the investment company of the Ernst Göhner Foundation, taking control stakes in established Swiss companies and growth positions in later-stage startups. It focuses on industry, IT, medical technology and pharmaceutical contract manufacturing, and requires a Swiss headquarters or substantial Swiss value creation, with established targets generating at least CHF 50 million in revenue. Returns from the portfolio fund the foundation's philanthropic work.

Past investments

Company Round Date Round size
Delvitech Mendrisio, Switzerland Series B Nov 2025 €34.5M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.